Latest Market News

Develop Global has landed a substantial A$274 million underground mining contract at Core Lithium’s Finniss Project, marking a major shift from Bellevue Gold and boosting its lithium services portfolio.

5E Advanced Materials secures a decade-long boric acid offtake agreement and advances boron product development, while reporting a $12.1 million quarterly loss and planning ASX delisting.

Arafura Rare Earths has secured a binding offtake term sheet with Traxys North America to supply 500 tonnes per annum of NdPr oxide, underpinning its Nolans Project and supporting US critical minerals supply chains.

Tungsten Mining has kicked off on-site preparations for a major drilling campaign at Mt Mulgine, aiming to significantly expand its tungsten resource and potentially define the world's largest deposit.

Barminco, Perenti's underground mining arm, has landed a significant A$850 million contract at Bellevue Gold Project, expanding its Australian footprint and requiring A$75 million growth capital in FY27.

Atomic Eagle’s initial drilling results at Chisebuka reveal a significant expansion of a higher-grade uranium zone, reinforcing the company’s 2026 resource growth ambitions at its flagship Muntanga Project in Zambia.

Commonwealth Bank of Australia reported a steady cash profit of around $2.7 billion in 3Q26, balancing disciplined lending growth and cautious provisioning amid geopolitical and economic uncertainties.

Marlin Global delivered a 4.0% gross portfolio return in April 2026, driven by strong gains in AI-focused tech stocks like Amazon and Alphabet. However, its cautious stance on semiconductors limited upside amid a sector rally.

Barramundi Limited outperformed the S&P/ASX200 in April with a 4.4% gross return, boosted by NEXT DC’s landmark data centre deal and capital raise, while healthcare stocks faced headwinds from Cochlear’s profit downgrade.

Kingfish Limited’s portfolio edged higher in April, buoyed by strong performances from Mercury and Infratil, while a2 Milk and Summerset weighed on returns amid operational and economic headwinds.

Pacific Edge has raised NZ$25.4 million through an oversubscribed placement priced at NZ$0.17 per share, aiming to bolster operations, support Medicare re-coverage efforts, and advance its bladder cancer diagnostic tests.

AoFrio’s first quarter revenue plunged 28% year-on-year, weighed down by the loss of a major US motor customer amid tariffs. The refrigeration tech firm is banking on new IoT product launches in Q2 to stabilise sales and improve profitability over 2026.